A selective eradication of human nonhereditary breast cancer cells by phenanthridine-derived polyADP-ribose polymerase inhibitors
-
* Corresponding author: Malka Cohen-Armon marmon@post.tau.ac.il
1 The Neufeld Cardiac Research Institute and Dept. of Physiology and Pharmacology, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel
2 Cancer Research Institute, Sheba Medical Center, Tel-Hashomer, Ramat-Gan 52621, Israel
3 Laboratory of Molecular and Structural Biology, Ecole Superieure de Biotechnologie de Strasbourg, F-67400, Illkrich-Graffenstaden, France
Breast Cancer Research 2009, 11:R78 doi:10.1186/bcr2445
See related editorial by Frizzell and Kraus, http://breast-cancer-research.com/content/11/6/111
Published: 9 November 2009Additional files
Additional file 1:
The following additional data are available with the online version of this article: A documented experiment, testing PJ-34 treatment in nude mice injected with MDA231 breast cancer cells (Additional data file 1).
Format: PDF Size: 1015KB Download file
This file can be viewed with: Adobe Acrobat Reader
